Stem cell homing

Current Opinion in Hematology

Volumn 13, Issue 6, 2006, Pages 399-406

  Chute, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelial cells; Hematopoiesis; Homing; Migration; Stem cells

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

BONE MARROW; CANCER STEM CELL; CELL ADHESION; CELL MIGRATION; HEMATOPOIETIC STEM CELL; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; ENDOTHELIAL CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, CXCR4;

EID: 33750212354     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/01.moh.0000245698.62511.3d     Document Type: Review

References (80)

1. Alpen E, Baum S. Modification of X-radiation lethality by autologous marrow infusion in dogs. Blood 1958; 13:1168-1175.
2. Mannick J, Lochte H, Ashley C, et al. Autografts of bone marrow in dogs after lethal total-body irradiation. Blood 1960; 15:255-266.
3. Buckner C, Epstein R, Rudolph R, et al. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood 1970; 35:741-750.
4. Thomas E, Storb R, Clift R, et al. Bone marrow transplantation. N Engl J Med 1975; 292:832-843.
5. Tavassoli M, Hardy C. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 1990; 76:1059-1070.
6. Mazo I, von Andrian U. Adhesion and homing of blood-borne cells in bone marrow microvessels. J Leukoc Biol 1999; 66:25-32.
7. Zanjani E, Flake A, Almeida-Porada G, et al. Homing of human cells in the fetal sheep model; modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 1999; 94:2515-2522.
8. Kollet O, Spiegel A, Peled A, et al. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/β2m(null) mice. Blood 2001; 97:3283-3291.
9. Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment in NOD/SCID mice. Blood 2000; 95:3289-3296.
10. Calvi L, Adams G, Weibrecht K, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841-846.
11. Avecilla S, Hattori K, Heissig B, et al. Chemokine mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10:64-71.
12. Sorrentino B. Clinical strategies for expansion of haematopoietic stem cells. Nat Immunol 2004; 4:878-888.
13. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836-841.
14. Kopp H, Avecilla S, Hooper A, et al. Tie-2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood 2005; 106:505-513. This study demonstrated the contribution of bone marrow vascular niche to hematopoietic recovery following myelosuppression.
15. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23:879-894. This is an excellent review of the mechanisms underlying normal stem cell mobilization and cancer stem cell metastasis.
16. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 2002; 109:625-637.
17. Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
18. Cottler-Fox M, Lapidot T, Petit I, et al. Stem cell mobilization. Hematology (Amer Soc Hematol Educ Book) 2003; 419-437.
19. Flomenberg N, Devine S, DiPersio J, et al. The use of AMD3100 plus GCSF for autologous hematopoietic progenitor cell mobilization is superior to GCSF alone. Blood 2005; 106:1867-1874. This study detailed the efficacy of the CXCR4 antagonist, AMD3100, to augment HSC mobilization for autologous transplantation.
20. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106:1901-1910. This is a definitive review of the biology of the CXCR4/SDF-1 interaction and its governance over the processes of stem cell homing, retention and mobilization.
21. Quesenberry P, Colvin G, Abedi M. Perspective: fundamental and clinical concepts on stem cell homing and engraftment: a journey to niches and beyond. Exp Hematol 2005; 33:9-19.
22. Potocnik A, Brakebusch C, Fassler R. Fetal and adult hematopoietic stem cells require b1 integrin function for colonizing fetal liver, spleen and bone marrow. Immunity 2000; 12:653-663.
23. Xia L, McDaniel J, Yago T, et al. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in the bone marrow. Blood 2004; 104:3091-3096.
24. Yang J, Hirata T, Croce K, et al. Targeted gene disruption demonstrates that P selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin but not E-selectin mediated neutrophil rolling and migration. J Exp Med 1999; 190:1769-1782.
25. Zou X, Shinde Patil V, Dagia N, et al. PSGL-1 derived from human neutrophils is a high efficiency ligand for endothelium expressed E-selectin under flow. Am J Physiol Cell Physiol 2005; 289:C415-C424.
26. Katayama Y, Hidalgo A, Furie B, et al. PSGL-1 participates in E-selectin mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and a4 integrin. Blood 2003; 102:2060-2067.
27. Mazo I, Gutierrez-Ramos J, Frenette P, et al. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998; 188:465-474.
28. Wright N, Hidalgo A, Rodriguez-Frade J, et al. The chemokine stromal derived factor-1 alpha modulates a4b7 integrin mediated lymphocyte adhesion to mucosal addressin molecule-1 and fibronectin. J Immunol 2002; 168:5268-5277.
29. Papayannapoulou T, Priestley G, Nakamoto B, et al. Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2) integrins and selectins. Blood 2001; 98:2403-2411.
30. Frenette P, Subbarao S, Mazo I, von Andrian U, Wagner D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor cell homing to bone marrow. Proc Natl Acad Sci USA 1998; 95:14423-14428.
31. Bonig H, Priestley G, Papayannopoulou T. Hierarchy of molecular pathway usage in bone marrow homing and its shift by cytokines. Blood 2006; 107:79-86. The dominant and compensatory role of the α4-integrin/VCAM-1 interaction in stem cell homing is delineated here and its cooperative role with SDF-1/CXCR-4 is also characterized.
32. Papayannapoulou T, Craddock C, Nakamoto B, et al. The VLA-4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hematopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995; 92:9647-9651.
33. Hirsch E, Iglesias A, Potocnik A, et al. Impaired migration but not differentiation of haematopoietic stem cells in the absence of b1 integrins. Nature 1996; 380:171-175.
34. Katayama Y, Hidalgo A, Peired A, Frenette P. Integrin α4β7 and its counter-receptor MadCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood 2004; 104:2020-2026.
35. Qian H, Tryggvason K, Jacobsen S, Ekblom M. Contribution of α6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with α4 integrins. Blood 2006; 107:3503-3510.
36. Avigdor A, Goichberg P, Shivtiel S, et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004; 104:2981-2989.
37. Vermeulen M, Le Pesteur F, Gagnerault M, et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998; 92:894-900.
38. Oostendorp R, Ghaffari S, Eaves C. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ specific but CD44 independent. Bone Marrow Transpl 2000; 26:559-566.
39. Sanz-Rodriguez F, Hidalgo A, Teixido J. Chemokine stromal cell derived factor-1 alpha modulates VLA-4-integrin mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 2001; 97:346-351.
40. Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest 1999; 104:1199-1211.
41. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845-848.
42. Voermans C, Kooi M, Rodenhuis S, et al. In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood 2001; 97:799-804.
43. Kahn J, Byk T, Jansson-Sjostrand L, et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004; 103:2942-2949.
44. Brenner S, Whiting-Theobald N, Kawai T, et al. CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 2004; 22:1128-1133.
45. Kollet O, Petit I, Kahn J, et al. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 2002; 100:2778-2786.
46. Rosu-Myles M, Gallacher L, Murdoch B, et al. The hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci USA 2000; 97:14626-14631.
47. Cashman J, Dykstra B, Clark-Lewis I, et al. Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors. J Exp Med 2002; 196:1141-1149.
48. Glimm H, Tang P, Clark-Lewis I, et al. Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice. Blood 2002; 99:3454-3457.
49. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002; 16:1992-2003.
50. Plett P, Frankovitz S, Wolber F, et al. Treatment of circulating CD34+ cells with SDF-1 alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential. Exp Hematol 2002; 30:1061.
51. Bonig H, Priestley G, Nilsson L, et al. PTX sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells. Blood 2004; 104:2299-2306.
52. Wiessman A, Spangrude G. Marrow engraftment of hematopoietic stem and progenitor cells is independent of G-alphai coupled chemokine receptors. Exp Hematol 1999; 27:946-955.
53. Christopherson K, Hangioc G, Mantel C, Broxmeyer H. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305:1000-1003.
54. Petit I, Goichberg P, Spiegel A, et al. Atypical PKC-zeta regulates SDF-1 mediated migration and development of human CD34+ progenitor cells. J Clin Invest 2005; 115:168-176.
55. Tavor S, Petit I, Porozov S, et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 2004; 64:2817-2824.
56. Monaco G, Belmont J, Konopleva M, et al. Correlation between CXCR4 and homing or engraftment of acute myelogous leukemia [letter]. Cancer Res 2004; 64:6832.
57. Lord B, Testa N, Hendry J. The relative spatial distribution of CFUs and CFUc in the normal mouse femur. Blood 1975; 46:65-72.
58. Gong J. Endosteal marrow: a rich source of hematopoietic stemcells. Science 1978; 199:1443-1445.
59. Cui Y, Lord B, Woolford L, Testa N. The relative spatial distribution of in vitro CFCs in the bone marrow, responding to specific growth factors. Cell Prolif 1996; 29:243-257.
60. Taichman R, Emerson S. Human osteoblasts support hematopoiesis through the production of granulocyte-colony stimulating factor. J Exp Med 1994; 179:1677-1682.
61. Adams G, Chabner K, Alley I, et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006; 439:599-603. This study demonstrated the mechanistic role of calcium ion and the calcium-sensing receptor in the migration and rentention of HSCs within the bone marrow endosteal niche.
62. Rafii S, Shapiro F, Pettengell R, et al. Human bone marrow microvascular endothelial cells support long term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995; 86:3353-3363.
63. Chute JP, Saini AA, Chute DJ, et al. Co-culture with human brain endothelial cells increases the SCID repopulating capacity of adult human bone marrow. Blood 2002; 100:4433-4439.
64. Chute JP, Muramoto G, Fung J, Oxford C. Soluble factors elaborated by human brain endothelial cell induce the concomitant expansion of purified BM CD34+CD38- cells and SCID repopulating cells. Blood 2005; 105:576-583.
65. Kiel M, Yilmaz O, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial cell niches for stem cells. Cell 2005; 121:1109-1121. The authors characterize novel cell surface markers for HSCs and demonstrate preferential residence of HSCs in association with bone marrow endothelial cells.
66. Van Der Loo J, Ploemacher R. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 1995; 85:2598-2606.
67. Van Hennick P, de Konig A, Ploemacher R. Seeding efficiency of primitive human hematopoietic cells in Nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency estimates. Blood 1999; 94:3055-3061.
68. Cashman J, Eaves C. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000; 96:3979-3981.
69. Wang J, Doedens M, Dick J. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating assay. Blood 1997; 89:3919-3924.
70. Benveniste P, Cantin C, Hyam D, Iscove N. Hematopoietic stem cells engraft in mice with absolute efficiency. Nat Immunol 2003; 7:708-713.
71. Matsuzaki Y, Kinjo K, Mulligan R, Okano H. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004; 20:87-93.
72. Bonnet D, Bhatia M, Wang J, et al. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses in NOD/SCID mice. Bone Marrow Transpl 1999; 23:203-209.
73. Adams G, Chabner K, Foxall R, et al. Heterologous cells cooperate to augment stem cell migration, homing and engraftment. Blood 2003; 101:45-51.
74. Levesque J, Hendy J, Takamatsu Y, et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111:187-196.
75. Fricker S, Anastassov V, Cox J, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 2006; 72:588-596. This article reviews the current state of understanding of the biology of AMD3100, a CXCR4 antagonist that is in clinical development.
76. Devine S, Flomenberg N, Vesole D, et al. Rapid mobilization of CD34+ cells following the administration of the CXCR4 antagonist. AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 2004; 22:1095-1102.
77. Grignani G, Perissinotto E, Cavalloni G, et al. Clinical use of AMD3100 to mobilize CD34+ cells in patients affected by non-Hodgkin's lymphoma or multiple myeloma. J Clin Oncol 2005; 23:3871-3872.
78. Schols D. HIV co-receptors as targets for antiviral therapy. Curr Top Med Chem 2004; 4:883-893.
79. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34+/CXCR4+, CD34+/CD117+, c-met+ stem cells and mononuclear cells expressing early cardiac, muscle and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110:3213-3220.
80. Misao Y, Takemura G, Arai M, et al. Importance of recruitment of bone marrow-derived CXCR4(+) in postinfarct cardiac repair mediated by GCSF. Cardiovasc Res 2006; 71:455-465.